RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)

Clinical trial NCT04832724 · COMPLETED

Trial details

NCT number: NCT04832724
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neovascular Age-related Macular Degeneration Wet Macular Degeneration Wet Age-related Macular Degeneration

Start date: 2021-02-22
Primary completion: 2023-10-02
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.